Different opinions over ways to access orphan drugs between industry and government

Over ways to increase patient accessibility for orphan drugs, the industrial field and the government have shown different approaches.

While the industrial field suggested to extend the scope of the Risk-Sharing Agreements(RSA) and the Special Economic Feasibility Evaluation System and create ways to preferentially treat the value or orphan drugs, the government stressed responsibilities on ph...